These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 2109653)
1. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653 [TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401 [TBL] [Abstract][Full Text] [Related]
3. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Reddy BS; Maruyama H; Kelloff G Cancer Res; 1987 Oct; 47(20):5340-6. PubMed ID: 3652039 [TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Reddy BS; Rivenson A; Kulkarni N; Upadhyaya P; el-Bayoumy K Cancer Res; 1992 Oct; 52(20):5635-40. PubMed ID: 1394188 [TBL] [Abstract][Full Text] [Related]
5. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis. Singh J; Kelloff G; Reddy BS Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Tanaka T; Kojima T; Suzui M; Mori H Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716 [TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412 [TBL] [Abstract][Full Text] [Related]
8. Effect of dietary excess of inorganic selenium during initiation and postinitiation phases of colon carcinogenesis in F344 rats. Reddy BS; Sugie S; Maruyama H; Marra P Cancer Res; 1988 Apr; 48(7):1777-80. PubMed ID: 3349457 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834 [TBL] [Abstract][Full Text] [Related]
10. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Reddy BS; Sugie S Cancer Res; 1988 Dec; 48(23):6642-7. PubMed ID: 3180073 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil. Nigro ND; Bull AW; Boyd ME J Natl Cancer Inst; 1986 Dec; 77(6):1309-13. PubMed ID: 3099048 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Reddy BS; Sugie S; Maruyama H; el-Bayoumy K; Marra P Cancer Res; 1987 Nov; 47(22):5901-4. PubMed ID: 3664491 [TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579 [TBL] [Abstract][Full Text] [Related]
14. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173 [TBL] [Abstract][Full Text] [Related]
15. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats. Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783 [TBL] [Abstract][Full Text] [Related]
16. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
17. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Singh J; Kulkarni N; Kelloff G; Reddy BS Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306 [TBL] [Abstract][Full Text] [Related]
18. Effect of different levels of calorie restriction on azoxymethane-induced colon carcinogenesis in male F344 rats. Kumar SP; Roy SJ; Tokumo K; Reddy BS Cancer Res; 1990 Sep; 50(18):5761-6. PubMed ID: 2393850 [TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Kawamori T; Lubet R; Steele VE; Kelloff GJ; Kaskey RB; Rao CV; Reddy BS Cancer Res; 1999 Feb; 59(3):597-601. PubMed ID: 9973206 [TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effects of dietary D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, on initiation and postinitiation stages of diethylnitrosamine-induced rat hepatocarcinogenesis. Kojima T; Tanaka T; Kawamori T; Hara A; Mori H Cancer Res; 1993 Sep; 53(17):3903-7. PubMed ID: 8358715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]